MTVA · MetaVia Inc
United States · RS rating 23 · As of 2026-11-03
| Price | 1.26 USD |
|---|---|
| 1-day change | +7.7% |
| RS rating (overall / 1M / 3M / 12M) | 23 / 23 / 37 / 6 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 15 / 6 / 20 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | -13.9% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +89.4% |
| Market cap (USD) | $7.7M |